LifeVantage (LFVN) Competitors $14.66 -0.90 (-5.78%) Closing price 04:00 PM EasternExtended Trading$14.67 +0.01 (+0.10%) As of 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LFVN vs. AVDL, COGT, OCS, CDMO, QURE, PRAX, AVXL, XERS, CMRX, and ABCLShould you be buying LifeVantage stock or one of its competitors? The main competitors of LifeVantage include Avadel Pharmaceuticals (AVDL), Cogent Biosciences (COGT), Oculis (OCS), Avid Bioservices (CDMO), uniQure (QURE), Praxis Precision Medicines (PRAX), Anavex Life Sciences (AVXL), Xeris Biopharma (XERS), Chimerix (CMRX), and AbCellera Biologics (ABCL). These companies are all part of the "pharmaceutical products" industry. LifeVantage vs. Avadel Pharmaceuticals Cogent Biosciences Oculis Avid Bioservices uniQure Praxis Precision Medicines Anavex Life Sciences Xeris Biopharma Chimerix AbCellera Biologics Avadel Pharmaceuticals (NASDAQ:AVDL) and LifeVantage (NASDAQ:LFVN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, community ranking, earnings, profitability, valuation, dividends and institutional ownership. Which has more risk & volatility, AVDL or LFVN? Avadel Pharmaceuticals has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Comparatively, LifeVantage has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Do insiders and institutionals hold more shares of AVDL or LFVN? 69.2% of Avadel Pharmaceuticals shares are held by institutional investors. Comparatively, 35.3% of LifeVantage shares are held by institutional investors. 4.8% of Avadel Pharmaceuticals shares are held by company insiders. Comparatively, 20.7% of LifeVantage shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts recommend AVDL or LFVN? Avadel Pharmaceuticals currently has a consensus target price of $19.88, suggesting a potential upside of 142.38%. LifeVantage has a consensus target price of $30.50, suggesting a potential upside of 108.05%. Given Avadel Pharmaceuticals' higher possible upside, research analysts plainly believe Avadel Pharmaceuticals is more favorable than LifeVantage.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avadel Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00LifeVantage 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is AVDL or LFVN more profitable? LifeVantage has a net margin of 3.46% compared to Avadel Pharmaceuticals' net margin of -52.53%. LifeVantage's return on equity of 34.29% beat Avadel Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Avadel Pharmaceuticals-52.53% -93.34% -44.77% LifeVantage 3.46%34.29%15.04% Does the MarketBeat Community prefer AVDL or LFVN? Avadel Pharmaceuticals received 126 more outperform votes than LifeVantage when rated by MarketBeat users. However, 77.97% of users gave LifeVantage an outperform vote while only 66.48% of users gave Avadel Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAvadel PharmaceuticalsOutperform Votes34966.48% Underperform Votes17633.52% LifeVantageOutperform Votes22377.97% Underperform Votes6322.03% Which has better valuation and earnings, AVDL or LFVN? LifeVantage has higher revenue and earnings than Avadel Pharmaceuticals. Avadel Pharmaceuticals is trading at a lower price-to-earnings ratio than LifeVantage, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvadel Pharmaceuticals$169.12M4.69-$160.28M-$0.52-15.77LifeVantage$212.15M0.87$2.94M$0.5626.18 Does the media prefer AVDL or LFVN? In the previous week, Avadel Pharmaceuticals had 1 more articles in the media than LifeVantage. MarketBeat recorded 3 mentions for Avadel Pharmaceuticals and 2 mentions for LifeVantage. Avadel Pharmaceuticals' average media sentiment score of 1.67 beat LifeVantage's score of 0.66 indicating that Avadel Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avadel Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive LifeVantage 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryLifeVantage beats Avadel Pharmaceuticals on 9 of the 17 factors compared between the two stocks. Remove Ads Get LifeVantage News Delivered to You Automatically Sign up to receive the latest news and ratings for LFVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFVN vs. The Competition Export to ExcelMetricLifeVantagePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$184.00M$6.99B$5.68B$8.32BDividend Yield0.98%2.72%4.55%4.02%P/E Ratio26.187.2324.5519.25Price / Sales0.87230.77395.7294.09Price / Cash19.0365.6738.1634.64Price / Book6.166.617.064.46Net Income$2.94M$142.13M$3.19B$247.07M7 Day Performance-10.23%2.79%1.49%3.05%1 Month Performance-16.61%2.70%5.87%-2.85%1 Year Performance133.81%-4.42%14.94%4.63% LifeVantage Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFVNLifeVantage3.3989 of 5 stars$14.66-5.8%$30.50+108.0%+125.5%$184.00M$212.15M26.18260Positive NewsAVDLAvadel Pharmaceuticals3.8019 of 5 stars$8.84+6.1%$19.88+124.8%-50.5%$854.20M$169.12M-11.1970Positive NewsCOGTCogent Biosciences2.0214 of 5 stars$7.39+3.5%$14.43+95.2%+15.8%$841.35MN/A-2.9880OCSOculis2.5621 of 5 stars$18.83+0.3%$29.50+56.7%+67.2%$822.16M$980,000.00-9.762CDMOAvid Bioservices1.0013 of 5 stars$12.50+0.1%$12.25-2.0%+85.7%$799.18M$139.91M-5.23320High Trading VolumeQUREuniQure1.935 of 5 stars$14.53+2.3%$38.89+167.6%+179.7%$785.74M$27.12M-2.93500News CoveragePRAXPraxis Precision Medicines2.9078 of 5 stars$38.93+1.7%$123.80+218.0%-30.0%$784.95M$8.55M-3.78110AVXLAnavex Life Sciences3.9097 of 5 stars$9.20-2.4%$44.00+378.3%+106.2%$782.59MN/A-16.7340News CoveragePositive NewsXERSXeris Biopharma3.4211 of 5 stars$5.03+4.4%$5.92+17.6%+179.5%$774.32M$203.07M-11.18290High Trading VolumeCMRXChimerix2.8532 of 5 stars$8.47+0.1%$8.53+0.7%+750.2%$761.76M$159,000.00-9.0190Earnings ReportAnalyst ForecastABCLAbCellera Biologics2.6123 of 5 stars$2.54+0.8%$7.00+175.6%-43.6%$756.89M$28.83M-4.16500Positive News Remove Ads Related Companies and Tools Related Companies Avadel Pharmaceuticals Competitors Cogent Biosciences Competitors Oculis Competitors Avid Bioservices Competitors uniQure Competitors Praxis Precision Medicines Competitors Anavex Life Sciences Competitors Xeris Biopharma Competitors Chimerix Competitors AbCellera Biologics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFVN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeVantage Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeVantage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LFVN Stock Free LFVN Stock Alerts